Navigation Links
Fourth IMPAKT Breast Cancer Conference
Date:4/25/2012

MEDIA ALERT

"Basic science and clinical medicine move at different pace because they follow different paths. Both however aim at improving strategies to manage cancer patients. We need to efficiently translate the good things from basic science and efficiently implement them in the clinic."

Sherene Loi and Fabrice Andr, IMPAKT 2012 Co-Chairs

IMPAKT 2012 will focus on four major areas:

  • Molecular pathology, the roots of personalized medicine beyond a microscope: emerging data confirms how valuable the role of the initial diagnosis based on the pathology report is and how this can impact treatment decisions
  • Prognostic multigene signature consensus: there is a clear need for a consensus opinion on the clinical relevance of the various prognostic signatures used by clinicians to make decisions on how to best treat patients. Top experts in the field will review the available literature and develop guidelines on how genetic signatures should be used
  • Triple negative breast cancer, a complex disease which requires intense discussions: how to improve survival of these patients with new drugs and new strategies especially after the failure of promising strategies like PARP inhibitors?
  • Tumor heterogeneity and metabolism, pathways to understand how to treat individual patients with new available targets in the era of personalized medicine: clinical implications and an open discussion on the molecular characteristics of cells with distinct phenotypes within the same tumor and on how cancer cells are metabolically rewired

Conference abstracts will be published on Wednesday, 25 April 2012 at 12:00 (CEST) and will be accessible at http://www.esmo.org/events/breast-2012-impakt/program.html

The IMPAKT 2012 Press Program will feature new study results on the following topics:

  • Breast cancer, not one disease
    '/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008
2. BIO-key(R) Announces Fourth Quarter and 2008 Year-End Earnings Release and Conference Call Schedule
3. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
4. BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008
5. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
6. BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability
7. MiMedx Group, Inc. Announces Release Date for 2010 Fourth Quarter and Full Year Results
8. AACR hosts Fourth Annual Science of Cancer Health Disparities Conference
9. Modern genetics answers age-old question on Garrods fourth inborn error of metabolism
10. Aware, Inc. Reports Fourth Quarter and 2011 Financial Results
11. IMPAKT -- Breast cancer conference highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... news release is available in German . ... chemical signals between organisms is considered the oldest form ... interactions between conspecifics, for example, the sexual attraction between ... social responses and to coordinate reproductive behavior in males ... the University of the Algarve in Faro, Portugal, and ...
(Date:8/29/2014)... the Tibetan plateau -- the largest topographic anomaly above ... its profound effect on climate and its reflection of ... Bulletin , Katharine Huntington and colleagues employ a cutting-edge ... and fossil snail shells to investigate the uplift history ... Views range widely on the timing of surface uplift ...
(Date:8/28/2014)... that an expansion of marine protected areas is needed ... According to investigators from the Wildlife Conservation Society ... focused on saving the largest numbers of species, often ... and difficult-to-replace ecological functions. , Many vital ... species that also are food for millions of people. ...
Breaking Biology News(10 mins):Ready for mating at the right time 2Ready for mating at the right time 3Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7Study finds marine protected areas inadequate for protecting fish and ocean ecology 2
... more than 30 researchers today gave a score to every ... world,s oceans, which showed the United States as being slightly ... leading concerns. The analysis, published in the journal ... 10 separate categories such as clean water, biodiversity, food provision, ...
... N.H., August 15, 2012 A new report by ... concludes that the climate of the Northeast has changed ... the effects of climate change on multiple aspects of ... and eastern Canada and concludes with recommendations on adaptive ...
... DNA sequencing is rapidly getting faster and cheaper, ... be able to use this information. In a contest ... the world are vying to interpret the DNA sequences ... a mystery—with the goal of establishing "best practices" for ...
Cached Biology News:Rating of ocean health shows 'room for improvement' 2Climate change effects, potential mitigation in Northeast forests subject of Forest Service Report 2Thirty teams compete to interpret three families' genomes 2Thirty teams compete to interpret three families' genomes 3Thirty teams compete to interpret three families' genomes 4Thirty teams compete to interpret three families' genomes 5
(Date:8/29/2014)... (PRWEB) August 29, 2014 Intrinsic ... 13485:2003 certified, GAMP® 5 compliant imaging core lab, ... international Phase II clinical trial to assess a ... Throughout this trial, Intrinsic Imaging will provide comprehensive ... to, protocol and charter development, site qualification, site ...
(Date:8/28/2014)... 28, 2014 “This kit has an improved ... from 0 to 150 ppb,” said Mark Tess, PhD, Mycotoxin ... benefit to plant owners and USDA-GIPSA inspection agencies that have ... Testing can take place in a matter of minutes with ... plant test the feed and grain before accepting it, but ...
(Date:8/28/2014)... The ability for organizations to attract ... allow individuals to perform at the highest of levels, ... looking to compete in this post–recession era. The ... as the sector increasingly focuses on the importance of ... have real results on the organization's development and the ...
(Date:8/28/2014)... 2014  Armetheon, Inc. ( www.armetheon.com ), a ... late-stage cardiovascular drug candidates, today announced that it ... of financing. The Series A round was co-led ... participation from investors that included Atheneos Capital and ... Larry Hsu , the founder of Impax Laboratories. ...
Breaking Biology Technology:Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3
... Dec 28 Thermo Fisher,Scientific Inc. (NYSE: TMO ... JPMorgan Healthcare Conference being held at the Westin St. ... on Monday, January,7, 2008, at 4:00 p.m. (PST)., ... Thermo,Fisher Scientific, will provide an overview of the company ...
... Perrigo Company,(Nasdaq: PRGO ; TASE) today ... U.S. Food and Drug Administration for its Abbreviated ... 5 and 10 mg., The product will ... comparable,to McNeil Consumer Healthcare,s Cetirizine Hydrochloride Tablets, 5 ...
... Raven ... merger, SOUTH SAN FRANCISCO, Calif., ... stockholders approved the proposed reverse split of its common stock by,a margin of ... permits VaxGen to reverse split its stock in a ratio of 4,5, or ...
Cached Biology Technology:Thermo Fisher Scientific to Present at the 26th Annual JPMorgan Healthcare Conference 2Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets 2VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal 2VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal 3VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal 4